Last updated: October 2026
You will prescribe eye drops every day of your career. This page summarises the drug groups residents use most, how they work, and the side effects and contraindications that examiners and patients care about.
| Class (examples) | Mechanism | Key side effects / cautions |
|---|---|---|
| Prostaglandin analogues (latanoprost, bimatoprost, travoprost) | Increase uveoscleral outflow | Once daily at night. Iris darkening, eyelash growth, periorbital fat atrophy, conjunctival redness. Use with caution in active uveitis and eyes at risk of CME. |
| Beta-blockers (timolol, betaxolol) | Reduce aqueous production | Bronchospasm, bradycardia, heart block. Avoid in asthma, COPD and heart block; betaxolol (cardioselective) is safer for the lungs but less effective. |
| Alpha-2 agonists (brimonidine, apraclonidine) | Reduce aqueous production and increase uveoscleral outflow | Allergic follicular conjunctivitis, dry mouth, fatigue. Avoid brimonidine in infants and young children because of CNS depression. |
| Carbonic anhydrase inhibitors (topical dorzolamide, brinzolamide; oral acetazolamide) | Reduce aqueous production | Topical: stinging, bitter taste. Oral: tingling, fatigue, kidney stones, low potassium, sulfa-type allergy. |
| Rho kinase inhibitors (netarsudil) | Increase trabecular outflow | Conjunctival redness, corneal verticillata, small subconjunctival haemorrhages. |
| Miotics (pilocarpine) | Increase trabecular outflow; pull the iris away from the angle | Brow ache, dim vision, myopic shift, and a small risk of retinal detachment. |
| Hyperosmotic agents (IV mannitol, oral glycerol) | Draw fluid out of the vitreous | Emergency use only. Caution in heart and kidney failure; oral glycerol raises blood sugar. |
Fixed combinations reduce the number of drops and improve adherence. See also AAO cap colour codes.
| Drug | Use | Notes |
|---|---|---|
| Tropicamide | Routine dilation | Short-acting; weak cycloplegia |
| Phenylephrine 2.5% / 10% | Dilation (adds to tropicamide) | 10% can raise blood pressure; prefer 2.5% in infants and patients with cardiovascular disease |
| Cyclopentolate | Cycloplegic refraction in children | Can cause CNS side effects (hallucinations, ataxia), especially in young children |
| Atropine | Strongest cycloplegia; uveitis; amblyopia penalisation; low-dose for myopia control | Effect can last up to about two weeks; watch for systemic toxicity in children |
| Drug | Ocular effect | What to do |
|---|---|---|
| Hydroxychloroquine | Bull's-eye maculopathy (often pericentral in Asian patients) | Keep the dose at or below 5 mg/kg of real body weight per day; baseline exam, then annual screening after 5 years (sooner if high risk) with OCT and visual fields |
| Ethambutol | Optic neuropathy (central scotoma, colour vision loss) | Baseline and regular checks of vision and colour vision; stop the drug if it occurs |
| Tamsulosin and other alpha-1 blockers | Intraoperative floppy iris syndrome | Always ask before cataract surgery; stopping the drug does not reliably prevent it |
| Topiramate | Bilateral acute angle closure from ciliochoroidal effusion, with a myopic shift | Stop the drug. Laser iridotomy does not help, because the mechanism is not pupil block. |
| Amiodarone | Vortex keratopathy; rarely optic neuropathy | Keratopathy rarely affects vision |
| Systemic corticosteroids | Cataract, raised IOP, CSCR | Monitor IOP and lens; ask about all routes, including inhalers and creams |
| Vigabatrin | Concentric visual field loss | Visual field monitoring |
Related: types of eye drops explained (patient guide) and landmark trials.
📘 Want more exam-ready material? See iNotes 2027: Basic Science & Optics on Kindle, or browse all my books.
Looking for an eye specialist in Ahmedabad? Read our patient guide to eye drops or book a consultation with Dr. Dhaval Patel.